These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1988610)

  • 1. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET.
    Gould KL; Yoshida K; Hess MJ; Haynie M; Mullani N; Smalling RW
    J Nucl Med; 1991 Jan; 32(1):1-9. PubMed ID: 1988610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
    Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
    Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial rubidium-82 tissue kinetics assessed by dynamic positron emission tomography as a marker of myocardial cell membrane integrity and viability.
    vom Dahl J; Muzik O; Wolfe ER; Allman C; Hutchins G; Schwaiger M
    Circulation; 1996 Jan; 93(2):238-45. PubMed ID: 8548894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability--what is the definition?
    Gropler RJ; Bergmann SR
    J Nucl Med; 1991 Jan; 32(1):10-2. PubMed ID: 1988611
    [No Abstract]   [Full Text] [Related]  

  • 5. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.
    Go RT; MacIntyre WJ; Cook SA; Neumann DR; Brunken RC; Saha GB; Underwood DA; Marwick TH; Chen EQ; King JL; Khandekar S
    J Nucl Cardiol; 1996; 3(2):96-104. PubMed ID: 8799234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
    Go RT; MacIntyre WJ; Saha GB; Cook SA; Neumann DR; Chen EQ; Underwood DA; Kaczur T
    Radiology; 1995 Jan; 194(1):151-5. PubMed ID: 7997543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial blood flow and glucose metabolism in patients with myocardial infarction evaluated by positron emission tomography: comparison with left ventriculography].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C; Senda M; Tamaki N; Yonekura Y
    J Cardiol; 1988 Mar; 18(1):13-20. PubMed ID: 3265437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.
    Camici P; Araujo LI; Spinks T; Lammertsma AA; Kaski JC; Shea MJ; Selwyn AP; Jones T; Maseri A
    Circulation; 1986 Jul; 74(1):81-8. PubMed ID: 3486725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial blood flow and glucose uptake after myocardial infarction.
    Rigo P; de Landsheere C; Raets D; Delfiore G; Quaglia L; Lemaire C; Peters JM; Guillaume M; Lamotte D; Kulbertus H
    Eur J Nucl Med; 1986; 12 Suppl():S59-61. PubMed ID: 3490379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of 18F-fluorodeoxyglucose positron emission tomography for evaluating myocardial viability in old myocardial infarction].
    Niwayama H; Yoshida K; Masuda Y; Inagaki Y
    Kaku Igaku; 1992 Nov; 29(11):1341-52. PubMed ID: 1484426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron imaging of myocardial infarction with rubidium-82.
    Goldstein RA; Mullani NA; Wong WH; Hartz RK; Hicks CH; Fuentes F; Smalling RW; Gould KL
    J Nucl Med; 1986 Dec; 27(12):1824-9. PubMed ID: 3491189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of T-wave inversion in Q-wave acute myocardial infarction to myocardial viability on resting rubidium-82 and 18-fluoro-deoxyglucose positron emission tomography imaging.
    Rosman J; Hanon S; Shapiro M; Schweitzer P; Van Tosh A
    Am J Cardiol; 2005 Jul; 96(1):42-4. PubMed ID: 15979430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of regional myocardial blood flow and energy metabolism].
    Yonekura Y; Senda M; Torizuka K
    J Cardiol Suppl; 1987; 15():65-9. PubMed ID: 3509973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction.
    Henrich MM; Vester E; von der Lohe E; Herzog H; Simon H; Kuikka JT; Feinendegen LE
    J Nucl Med; 1991 Jul; 32(7):1353-7. PubMed ID: 2066789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography.
    Doyle WK; Budinger TF; Valk PE; Levin VA; Gutin PH
    J Comput Assist Tomogr; 1987; 11(4):563-70. PubMed ID: 3496366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine stimulation, substrate competition, and myocardial glucose uptake in conscious dogs assessed with positron emission tomography.
    Merhige ME; Ekas R; Mossberg K; Taegtmeyer H; Gould KL
    Circ Res; 1987 Nov; 61(5 Pt 2):II124-9. PubMed ID: 3311449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.